Our lab receives funding from various sources that include the National Institutes of Health, philanthropic organizations, institutional organizations, and individual gifts. A list of current and past grants where we direct or collaborate on research projects is shown below.
National Institutes of Health
NIH R01 EY037830
Integrated Molecular Profiling of Diabetic Retinopathy
4/27/2020 – 9/30/2021
DOE BER 100651
Molecular design and analysis to inform therapeutics related to COVID-19
9/2025 – 8/2028
NIH R01 EY031360
Improving rigor and reproducibility in adaptive optics ophthalmoscopy
1/01/20-6/30/24
NIH R01 EY031952
Proteomic Biomarkers of Intraocular Infection
8/01/20-7/31/24
NIH R01 EY030151
Inflammatory Gene Transcription in the Retina
1/01/20-12/31/24
NIH P30 EY026877
Stanford Vision Research Core
9/30/17-6/30/22
NIH R01 NS-98950
Exploring novel epilepsy pathways
5/15/16-2/28/21
NIH R01 AR59703
Genetic and immunologic etiology of chronic recurrent multifocal osteomylitis (CRMO)
9/28/15-8/31/20
NIH R01 EY-26682
Mechanistic studies on regenerative medicine approaches to childhood blindness
4/1/16-03/31/20
NIH R01 EY-24698
Gene silencing and gene editing in phototransduction
9/1/15-6/30/19
NIH R01 EY-24665
Structure and function of Calpain-5
12/1/14-11/30/19
NIH R01 EY-25225
Mechanism-based therapies for photoreceptor degeneration
5/1/15-4/30/19
NIH R21 AG-50437
Evaluating GWAS AMD candidate loci by gene editing in human IPS cells
4/15/15-3/31/18
NIH K08 EY020530
Molecular Genetics of Dominant Neovascular Inflammatory Vitreoretinopathy
02/01/11 – 01/31/16
Training Grants
NIH T32 (Mentor)
Stanford Vision Research Training Program: Drug Design
7/2022 - 8/2023
Major grant Vice Provost of Undergraduate Education (Mentor)
Drug implant development
7/2022-9/2022
Bright Focus Macular Degeneration Award (Mentor)
4/2021-5/2023
VitreoRetinal Surgery Foundation Research Award (Mentor)
Endophthalmitis Proteomics
11/2020 - 5/2021
Bio-X Undergraduate Summer Research Program (Mentor)
Proteomics of Vitreoretinal Disease
06/2020 - 09/2020
NIH T32 (Mentor)
Stanford Vision Research Training Program: Drug Design
3/2020 - 3/2021
ChEM-H Undergraduate Scholars Program (Mentor)
01/2020 - 09/2020
NIH F30 EY027986 (Mentor)
Structure-function studies of Calpain-5 in hereditary uveitis
03/2018 - 03/2022
NIH-F31 EY026789-02 (Mentor)
CAPN5 –PDGF Signaling in Vitreoretinopathy
04/15/2016-03/31/2021
NIH 5F32EY022280 (Mentor)
Molecular Mechanisms of SOD3 and Oxidative Stress in Diabetic Vitreoretinopathy
5/2012-5/2015
Foundations
Doris Duke Charitable Foundation
Data Sharing Eye Proteomics
1/2020 - 1/2021
Research to Prevent Blindness
Research Collaborations
9/2018 - 8/2022
Doris Duke Charitable Foundation
Clinical Scientist Development Award
Molecular Genetic Mechanisms of Calpain-5 Autoimmunity
7/2013 - 6/2017
Research to Prevent Blindness.
Molecular Genetics of ADNIV
9/2011 – 10/2016
Bright Focus
Cytokine Signaling in the Foveal Choroid in AMD
7/2011 – 6/2013
Fight for Sight
Molecular Genetics of Retinal Detachment
7/2009 – 6/2012
A.P. Giannini Foundation
7/2003 – 6/2005
Institutional
Stanford ChEM-H COVID-19 Response: Drug and Vaccine Prototyping
Inhibition of host serine proteases
6/2020 - 7/2021
Stanford Alliance for Innovative Medicines
Target-driven Drug Discovery
1/2019 - 12/2019
ChEM-H Testing Molecular Hypotheses in Human Subjects
Vitreous Proteases
3/2018 - 2/2019